Skip to content
Abierto
Menu

Award notice

Award Announcement - Research and Development Services for the research study titled “Therapeutic Effects of the PTP Inhibitor (NVG-291) on Sensorineural Hearing Loss After Precise Blastinduced Auditory Injury” Contract Number HT9425-24-C-0111

HT9425-24-LWR-AOA

Defense Health Agency (Dha), Army Med Res Acq Activity. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

The Geneva Foundation

$561,042.00 on the award notice, September 20, 2024, contract HT9425-24-C-0111

Description

As published on SAM.gov.

Award Announcement for "Therapeutic Effects of the PTP Inhibitor (NVG-291) on Sensorineural Hearing Loss After Precise Blast-Induced Auditory Injury”. See J&A.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
The Geneva Foundation
UEI
TR9RX33188T4
CAGE
1D2D1
Vendor location
Tacoma, WA
Contract
HT942524C0111, definitive contract
Obligated
$561,042.00
Actions
3 between September 20, 2024 and September 16, 2025
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Research and Development Services
Match
award number HT942524C0111 equals the contract number; same awarding office HT9425 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 26, 2024

    Award notice, originally special notice

    Awarded to THE GENEVA FOUNDATION Tacoma for $561,042. SAM.gov, notice 506a282f6b6f4679afd1605f41b33acf

Points of contact

Also open from this buyer